CENTOGENE N.V.

CNTG
Delayed Quote. Delayed  - 07/30 03:59:51 pm
11.36USD -1.22%

Turn to zoom
Prev.11.5000
Open11.4200
High11.5050
Low11.3000
Volume16 606
Latest news
3d ago
3d ago
3d ago
06/25
Chart CENTOGENE N.V.
Technical analysis trends
Short TermMid-TermLong Term
TrendNeutralNeutralNeutral
Resistance11,713,913,0
Spread/Res.-3,1%-19%-13%
Spread/Supp.15%26%20%
Support9,869,029,44
Financials
Sales 2021 144 M 171 M 171 M
Net income 2021 -28,3 M -33,6 M -33,6 M
Net cash 2021 13,7 M 16,3 M 16,3 M
P/E ratio 2021 -7,51x
Yield 2021 -
Capitalization 215 M 255 M 255 M
EV / Sales 2021 1,40x
EV / Sales 2022 3,10x
Nbr of Employees 660
Free-Float 40,0%
Company
Centogene BV is a Germany-based company engaged in the rare disease market. It focuses on transforming clinical, genetic and biochemical data into medical solutions for patients, physicians and pharmaceutical companies. The Company provides the full spectrum of methods and technology for human...

>> Read more
Sector :
Other Biotechnology & Medical Research
Calendar :
2021-09-29 Earnings Release
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Mean consensus BUY
Number of Analysts 4
Last Close Price 9,57 €
Average target price 16,30 €
Spread / Average Target 70,3%